Introduction
The Recombinant Human SS18L1 Protein is a highly purified and biologically active protein that is produced through recombinant DNA technology. It is a member of the SS18 family of proteins and is encoded by the SS18L1 gene. This protein plays a crucial role in various cellular processes, making it a valuable tool for scientific research and potential therapeutic applications.
Structure of Recombinant Human SS18L1 Protein
The Recombinant Human SS18L1 Protein is a 98 kDa protein consisting of 888 amino acids. It contains a conserved SNH domain, which is characteristic of the SS18 family of proteins. This domain is responsible for the protein’s ability to interact with other proteins and play a role in various cellular processes.
The protein is produced in a mammalian expression system, ensuring proper folding and post-translational modifications, such as glycosylation, that are essential for its biological activity. The recombinant protein is purified using advanced chromatography techniques, resulting in a highly pure and stable product.
Activity of Recombinant Human SS18L1 Protein
The Recombinant Human SS18L1 Protein is a transcriptional regulator that plays a critical role in chromatin remodeling and gene expression. It interacts with other proteins, such as the SWI/SNF chromatin remodeling complex, to regulate the expression of various genes involved in cell growth, differentiation, and development.
Studies have shown that SS18L1 is highly expressed in embryonic stem cells and is essential for maintaining their pluripotency and self-renewal capabilities. It has also been implicated in the development of various tissues and organs, including the brain, heart, and skeletal muscle.
Furthermore, the Recombinant Human SS18L1 Protein has been shown to play a role in cancer development. It is overexpressed in certain types of cancers, such as synovial sarcoma, and has been linked to tumor growth and metastasis. Therefore, understanding the activity of this protein can provide valuable insights into the mechanisms of cancer development and may lead to the development of new therapeutic strategies.
Application of Recombinant Human SS18L1 Protein
The Recombinant Human SS18L1 Protein has a wide range of applications in scientific research. It can be used as an antigen for the production of specific antibodies to study the protein’s expression, localization, and function in different cell types and tissues.
The protein can also be used in biochemical assays to study its interactions with other proteins and its role in chromatin remodeling and gene expression. This can provide valuable information about the protein’s activity and its involvement in various cellular processes.
Moreover, the Recombinant Human SS18L1 Protein has potential therapeutic applications. Due to its role in cancer development, it is being investigated as a potential target for cancer treatment. Inhibitors of SS18L1 have shown promising results in pre-clinical studies, and further research is being conducted to develop more effective and specific inhibitors for clinical use.
Conclusion
The Recombinant Human SS18L1 Protein is a highly valuable tool for scientific research and has potential therapeutic applications. Its well-defined structure, activity, and various applications make it a crucial protein in understanding cellular processes and developing new treatments for diseases, particularly cancer. With ongoing research and advancements in recombinant DNA technology, the potential of this protein in both basic and applied science is vast and promising.
There are no reviews yet.